» Articles » PMID: 28297712

CD32a is a Marker of a CD4 T-cell HIV Reservoir Harbouring Replication-competent Proviruses

Overview
Journal Nature
Specialty Science
Date 2017 Mar 16
PMID 28297712
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

The persistence of the HIV reservoir in infected individuals is a major obstacle to the development of a cure for HIV. Here, using an in vitro model of HIV-infected quiescent CD4 T cells, we reveal a gene expression signature of 103 upregulated genes that are specific for latently infected cells, including genes for 16 transmembrane proteins. In vitro screening for surface expression in HIV-infected quiescent CD4 T cells shows that the low-affinity receptor for the immunoglobulin G Fc fragment, CD32a, is the most highly induced, with no detectable expression in bystander cells. Notably, productive HIV-1 infection of T-cell-receptor-stimulated CD4 T cells is not associated with CD32a expression, suggesting that a quiescence-dependent mechanism is required for its induction. Using blood samples from HIV-1-positive participants receiving suppressive antiretroviral therapy, we identify a subpopulation of 0.012% of CD4 T cells that express CD32a and host up to three copies of HIV DNA per cell. This CD32a reservoir was highly enriched in inducible replication-competent proviruses and can be predominant in some participants. Our discovery that CD32a lymphocytes represent the elusive HIV-1 reservoir may lead to insights that will facilitate the specific targeting and elimination of this reservoir.

Citing Articles

Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places.

Chen W, Berkhout B, Pasternak A Curr HIV/AIDS Rep. 2025; 22(1):15.

PMID: 39903363 PMC: 11794352. DOI: 10.1007/s11904-025-00723-6.


Single cell spatial profiling of FFPE splenic tissue from a humanized mouse model of HIV infection.

Wu G, Keller S, Sardo L, Magliaro B, Zuck P, Balibar C Biomark Res. 2024; 12(1):116.

PMID: 39380117 PMC: 11462831. DOI: 10.1186/s40364-024-00658-x.


HIV Reservoirs and Treatment Strategies toward Curing HIV Infection.

Matsuda K, Maeda K Int J Mol Sci. 2024; 25(5).

PMID: 38473868 PMC: 10932120. DOI: 10.3390/ijms25052621.


Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?.

Harper J, Betts M, Lichterfeld M, Muller-Trutwin M, Margolis D, Bar K Pathog Immun. 2024; 8(2):115-157.

PMID: 38455668 PMC: 10919397. DOI: 10.20411/pai.v8i2.665.


Single-cell RNA sequencing reveals common and unique gene expression profiles in primary CD4+ T cells latently infected with HIV under different conditions.

Zhang X, Qazi A, Deshmukh S, Lobato Ventura R, Mukim A, Beliakova-Bethell N Front Cell Infect Microbiol. 2023; 13:1286168.

PMID: 38156317 PMC: 10754520. DOI: 10.3389/fcimb.2023.1286168.